198 related articles for article (PubMed ID: 35007329)
1. Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
Boyko EJ; Zelnick LR; Braffett BH; Pop-Busui R; Cowie CC; Lorenzi GM; Gubitosi-Klug R; Zinman B; de Boer IH
Diabetes Care; 2022 Feb; 45(2):357-364. PubMed ID: 35007329
[TBL] [Abstract][Full Text] [Related]
2. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
DCCT/EDIC research group
Lancet Diabetes Endocrinol; 2014 Oct; 2(10):793-800. PubMed ID: 25043685
[TBL] [Abstract][Full Text] [Related]
3. Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort.
Kim C; Cleary PA; Cowie CC; Braffett BH; Dunn RL; Larkin ME; Gatcomb PM; Wessells HB; Nathan DM; Sarma AV;
Diabetes Care; 2014; 37(3):701-8. PubMed ID: 24170751
[TBL] [Abstract][Full Text] [Related]
4. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
[TBL] [Abstract][Full Text] [Related]
5. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
Martin CL; Albers JW; Pop-Busui R;
Diabetes Care; 2014; 37(1):31-8. PubMed ID: 24356595
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real-world data from the German/Austrian DPV registry.
Eckert AJ; Zimny S; Altmeier M; Dugic A; Gillessen A; Bozkurt L; Götz G; Karges W; Wosch FJ; Kress S; Holl RW;
J Diabetes; 2024 Feb; 16(2):e13531. PubMed ID: 38403299
[TBL] [Abstract][Full Text] [Related]
7. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
JAMA; 2003 Oct; 290(16):2159-67. PubMed ID: 14570951
[TBL] [Abstract][Full Text] [Related]
8. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
de Boer IH;
Diabetes Care; 2014; 37(1):24-30. PubMed ID: 24356594
[TBL] [Abstract][Full Text] [Related]
9. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
Albers JW; Herman WH; Pop-Busui R; Feldman EL; Martin CL; Cleary PA; Waberski BH; Lachin JM;
Diabetes Care; 2010 May; 33(5):1090-6. PubMed ID: 20150297
[TBL] [Abstract][Full Text] [Related]
10. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Braffett BH; Gubitosi-Klug RA; Albers JW; Feldman EL; Martin CL; White NH; Orchard TJ; Lopes-Virella M; Lachin JM; Pop-Busui R;
Diabetes; 2020 May; 69(5):1000-1010. PubMed ID: 32051148
[TBL] [Abstract][Full Text] [Related]
12. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP;
Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Pop-Busui R; Braffett BH; Zinman B; Martin C; White NH; Herman WH; Genuth S; Gubitosi-Klug R;
Diabetes Care; 2017 Jan; 40(1):94-100. PubMed ID: 27803120
[TBL] [Abstract][Full Text] [Related]
14. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.
Genuth S
Endocr Pract; 2006; 12 Suppl 1():34-41. PubMed ID: 16627378
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
White NH; Cleary PA; Dahms W; Goldstein D; Malone J; Tamborlane WV;
J Pediatr; 2001 Dec; 139(6):804-12. PubMed ID: 11743505
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Neuropathy, Glycemic Control, and Revascularization as Risk Factors for Future Lower Extremity Amputation among Diabetic Patients.
Goldman MP; Corriere MA; Craven T; Davis RP; Sheehan M; Hurie JB; Velazquez G; Williams TK; Chang K; Edwards MS
Ann Vasc Surg; 2021 May; 73():254-263. PubMed ID: 33248240
[TBL] [Abstract][Full Text] [Related]
17. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
Lachin JM; Orchard TJ; Nathan DM;
Diabetes Care; 2014; 37(1):39-43. PubMed ID: 24356596
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and risk factors of lower extremity amputation in the diabetic inpatients with foot ulcers.
Gong H; Ren Y; Li Z; Zha P; Bista R; Li Y; Chen D; Gao Y; Chen L; Ran X; Wang C
Front Endocrinol (Lausanne); 2023; 14():1144806. PubMed ID: 37065766
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome and determinants of amputation in a large cohort of Iranian patients with diabetic foot ulcers.
Niakan MH; Dehghankhalili M; Pourdavood A; Vahidi A; Nazemi S; Piranviseh A; Hasanvand K
Foot (Edinb); 2020 Dec; 45():101688. PubMed ID: 33011496
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study.
Hainsworth DP; Bebu I; Aiello LP; Sivitz W; Gubitosi-Klug R; Malone J; White NH; Danis R; Wallia A; Gao X; Barkmeier AJ; Das A; Patel S; Gardner TW; Lachin JM;
Diabetes Care; 2019 May; 42(5):875-882. PubMed ID: 30833368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
